IVF INVO FERTILITY INC. revenue, earnings and financials
For the quarter ended June 30, 2026, INVO FERTILITY INC. reported revenue of $2.18M (up 16.7% from a year earlier), net income of $889K and diluted EPS of $0.35; over the last four quarters revenue was $7.53M and net income $39.7M; for the fiscal year ended December 2025 revenue was $6.84M, up 4.7% on the year before.
IVF annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $6.84M, gross profit n/a, operating income −$7.24M, net income $23.3M (margin 340.9%), EPS −$214.64
- Fiscal year ended Dec 2024: revenue $6.53M, gross profit n/a, operating income −$6.63M, net income $9.05M (margin 138.6%), EPS −$3782.65
- Fiscal year ended Dec 2023: revenue $3.02M, gross profit n/a, operating income −$6.77M, net income $8.03M (margin 266.0%), EPS −$67.37
- Fiscal year ended Dec 2022: revenue $822K, gross profit $491K, operating income −$10.6M, net income −$10.9M (margin -1324.8%), EPS −$17.97
- Fiscal year ended Dec 2021: revenue $4.16M, gross profit $4.02M, operating income −$5.22M, net income −$6.65M (margin -160.0%), EPS −$0.63
IVF quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $2.18M (up 16.7% year over year), net income $889K, EPS $0.35
- Quarter ended Mar 31, 2026: revenue $2.02M (up 23.1% year over year), net income −$5.54M, EPS −$3.38
- Quarter ended Dec 31, 2025 (from the annual report): revenue $1.58M (down 6.1% year over year), net income $47.7M, EPS $3662.92
- Quarter ended Sep 30, 2025: revenue $1.76M (up 22.6% year over year), net income −$3.40M, EPS −$39.40
- Quarter ended Jun 30, 2025: revenue $1.86M (up 1.5% year over year), net income −$3.62M, EPS −$364.23
- Quarter ended Mar 31, 2025: revenue $1.64M (up 3.9% year over year), net income −$17.4M, EPS −$3473.93
- Quarter ended Dec 31, 2024 (from the annual report): revenue $1.69M (up 22.0% year over year), net income $14.5M, EPS −$3737.60
- Quarter ended Sep 30, 2024: revenue $1.43M (up 47.0% year over year), net income −$1.63M, EPS −$15.11
- Quarter ended Jun 30, 2024: revenue $1.84M (up 481.4% year over year), net income −$2.25M, EPS −$22.39
- Quarter ended Mar 31, 2024: revenue $1.58M (up 352.9% year over year), net income −$1.60M, EPS −$7.55
- Quarter ended Dec 31, 2023 (from the annual report): revenue $1.38M (up 396.8% year over year), net income $14.1M, EPS −$59.51
- Quarter ended Sep 30, 2023: revenue $975K (up 314.3% year over year), net income −$1.25M, EPS −$0.70
- Quarter ended Jun 30, 2023: revenue $316K (up 116.2% year over year), net income −$2.24M, EPS −$3.06
- Quarter ended Mar 31, 2023: revenue $348K (up 114.0% year over year), net income −$2.55M, EPS −$4.10
- Quarter ended Dec 31, 2022 (from the annual report): revenue $278K (down 90.9% year over year), net income −$2.77M, EPS −$8.93
- Quarter ended Sep 30, 2022: revenue $235K (up 7.5% year over year), net income −$2.55M, EPS −$4.19
- Quarter ended Jun 30, 2022: revenue $146K (down 29.9% year over year), net income −$2.80M, EPS −$4.62
- Quarter ended Mar 31, 2022: revenue $163K (down 76.2% year over year), net income −$2.77M, EPS −$0.23
- Quarter ended Dec 31, 2021 (from the annual report): revenue $3.05M, net income −$142K, EPS $0.03
- Quarter ended Sep 30, 2021: revenue $219K, net income −$2.24M, EPS −$0.24
IVF cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$7.01M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$2.97M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$4.76M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$6.60M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$6.03M, share buybacks n/a
IVF balance sheet
- Jun 30, 2026: cash n/a, total assets $25.8M, total liabilities $9.34M, shareholders' equity $16.5M, long-term debt $513K
- Mar 31, 2026: cash n/a, total assets $24.7M, total liabilities $9.63M, shareholders' equity $15.0M, long-term debt $660K
- Dec 31, 2025: cash n/a, total assets $20.2M, total liabilities $13.0M, shareholders' equity $7.22M, long-term debt $745K
- Sep 30, 2025: cash n/a, total assets $18.8M, total liabilities $13.0M, shareholders' equity $5.82M, long-term debt $952K
- Jun 30, 2025: cash n/a, total assets $19.3M, total liabilities $16.2M, shareholders' equity −$7.15M, long-term debt $1.04M
- Mar 31, 2025: cash n/a, total assets $31.7M, total liabilities $24.4M, shareholders' equity −$27.2M
- Dec 31, 2024: cash n/a, total assets $46.1M, total liabilities $26.0M, shareholders' equity $12.6M, long-term debt $1.13M
- Sep 30, 2024: cash n/a, total assets $17.0M, total liabilities $17.0M, shareholders' equity −$23.3K
What is IVF's revenue?
INVO FERTILITY INC. reported $7.53M of revenue over its last four quarters, through June 30, 2026.
Is IVF profitable?
Yes. INVO FERTILITY INC. earned $39.7M over the last four quarters.
What is IVF's EPS?
Diluted earnings per share over the last four quarters were $3620.49; $0.35 in the latest quarter.